HEMISPHERX BIOPHARMA INC·4

Jul 19, 12:50 PM ET

PASCALE ADAM 4

4 · HEMISPHERX BIOPHARMA INC · Filed Jul 19, 2018

Insider Transaction Report

Form 4
Period: 2018-07-18
Pascale Adam
Chief Accounting Officer
Transactions
  • Award

    Options to buy Common Stock

    2018-07-18+53,76353,763 total
    Exercise: $0.31From: 2018-07-18Exp: 2028-07-18Common Stock (53,763 underlying)
Footnotes (1)
  • [F1]This option is being issued to senior management in exchange for a voluntary 40% deferral in salary.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT